Warby Parker (WRBY) Stock Forecast, Price Target & Predictions
WRBY Stock Forecast
Warby Parker stock forecast is as follows: an average price target of $17.00 (represents a -3.24% downside from WRBY’s last price of $17.57) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.
WRBY Price Target
WRBY Analyst Ratings
Warby Parker Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 29, 2024 | Paul Lejuez | Citigroup | $15.00 | $17.21 | -12.84% | -14.63% |
Oct 21, 2024 | Brooke Roach | Goldman Sachs | $18.00 | $16.55 | 8.76% | 2.45% |
Sep 27, 2024 | Ana Garcia | CFRA | $20.00 | $16.03 | 24.77% | 13.83% |
Aug 23, 2024 | Nicholas Jones | JMP Securities | $20.00 | $13.86 | 44.30% | 13.83% |
Aug 22, 2024 | Anna Andreeva | Piper Sandler | $18.00 | $13.86 | 29.87% | 2.45% |
Aug 08, 2024 | Jim Duffy | Stifel Nicolaus | $15.00 | $14.04 | 6.84% | -14.63% |
Jul 10, 2024 | Anthony Chukumba | Loop Capital Markets | $16.00 | $15.64 | 2.30% | -8.94% |
May 10, 2024 | Anthony Chukumba | Loop Capital Markets | $15.00 | $15.03 | -0.20% | -14.63% |
May 10, 2024 | Mark Carden | UBS | $15.00 | $15.33 | -2.15% | -14.63% |
May 09, 2024 | Mark Mahaney | Evercore ISI | $19.00 | $14.63 | 29.89% | 8.14% |
Warby Parker Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 6 | 10 |
Avg Price Target | $16.50 | $17.67 | $17.10 |
Last Closing Price | $17.57 | $17.57 | $17.57 |
Upside/Downside | -6.09% | 0.57% | -2.68% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 29, 2024 | Citigroup | Neutral | Neutral | Hold |
Oct 21, 2024 | Telsey Advisory | Market Outperform | Market Outperform | Hold |
Oct 21, 2024 | Piper Sandler | Underperform | Underperform | Hold |
Oct 21, 2024 | Goldman Sachs | - | Buy | Upgrade |
Oct 03, 2024 | Loop Capital Markets | Hold | Hold | Hold |
Sep 27, 2024 | CFRA | Buy | Buy | Hold |
Aug 23, 2024 | Piper Sandler | Underperform | Underperform | Hold |
Aug 23, 2024 | Telsey Advisory | Market Outperform | Market Outperform | Hold |
Aug 22, 2024 | JMP Securities | - | Outperform | Upgrade |
Aug 01, 2024 | Telsey Advisory | Underperform | Underperform | Hold |
Warby Parker Financial Forecast
Warby Parker Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $169.85M | $166.09M | $171.97M | $146.49M | $148.78M | $149.62M | $153.22M | $132.89M | $137.37M |
Avg Forecast | $207.94M | $216.67M | $212.92M | $223.78M | $183.14M | $190.14M | $187.03M | $196.41M | $160.85M | $164.70M | $162.56M | $166.75M | $142.56M | $144.68M | $149.50M | $154.08M | $133.35M | $133.03M |
High Forecast | $207.94M | $216.67M | $212.92M | $223.78M | $183.14M | $190.89M | $187.03M | $196.41M | $164.29M | $164.71M | $162.56M | $166.75M | $142.56M | $144.68M | $149.50M | $154.08M | $133.35M | $133.03M |
Low Forecast | $207.94M | $216.67M | $212.92M | $223.78M | $183.14M | $189.30M | $187.03M | $196.41M | $159.15M | $164.69M | $162.56M | $166.75M | $142.56M | $144.68M | $149.50M | $154.08M | $133.35M | $133.03M |
# Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.03% | 1.02% | 1.03% | 1.03% | 1.03% | 1.00% | 0.99% | 1.00% | 1.03% |
Warby Parker EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
EBITDA | - | - | - | - | - | - | - | - | - | $-19.77M | $-18.23M | $-3.29M | $-21.71M | $-15.74M | $-24.20M | $-26.60M | $-39.24M | $-86.48M |
Avg Forecast | $-19.45M | $-20.27M | $-19.92M | $-20.93M | $-17.13M | $-17.79M | $-17.50M | $-18.37M | $-15.05M | $-15.41M | $-15.21M | $-15.60M | $-13.34M | $-13.53M | $-13.99M | $-14.41M | $-12.47M | $-12.44M |
High Forecast | $-19.45M | $-20.27M | $-19.92M | $-20.93M | $-17.13M | $-17.71M | $-17.50M | $-18.37M | $-14.89M | $-15.41M | $-15.21M | $-15.60M | $-13.34M | $-13.53M | $-13.99M | $-14.41M | $-12.47M | $-12.44M |
Low Forecast | $-19.45M | $-20.27M | $-19.92M | $-20.93M | $-17.13M | $-17.86M | $-17.50M | $-18.37M | $-15.37M | $-15.41M | $-15.21M | $-15.60M | $-13.34M | $-13.53M | $-13.99M | $-14.41M | $-12.47M | $-12.44M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.28% | 1.20% | 0.21% | 1.63% | 1.16% | 1.73% | 1.85% | 3.15% | 6.95% |
Warby Parker Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
Net Income | - | - | - | - | - | - | - | - | - | $-17.41M | $-15.93M | $-10.81M | $-20.25M | $-23.84M | $-32.17M | $-34.13M | $-45.90M | $-91.07M |
Avg Forecast | $7.19M | $11.06M | $9.86M | $12.49M | $2.86M | $6.28M | $6.21M | $8.15M | $802.18K | $935.23K | $2.77M | $5.40M | $-85.74K | $3.19M | $-2.53M | $522.26K | $-10.82M | $-62.79M |
High Forecast | $7.19M | $11.06M | $9.86M | $12.49M | $2.86M | $8.80M | $6.23M | $8.16M | $821.39K | $935.23K | $2.77M | $5.40M | $-85.74K | $3.19M | $-2.53M | $522.26K | $-10.82M | $-62.79M |
Low Forecast | $7.19M | $11.06M | $9.86M | $12.49M | $2.86M | $3.77M | $6.19M | $8.15M | $782.96K | $935.23K | $2.77M | $5.40M | $-85.74K | $3.19M | $-2.53M | $522.26K | $-10.82M | $-62.79M |
Surprise % | - | - | - | - | - | - | - | - | - | -18.62% | -5.76% | -2.00% | 236.19% | -7.47% | 12.69% | -65.36% | 4.24% | 1.45% |
Warby Parker SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
SG&A | - | - | - | - | - | - | - | - | - | $112.50M | $108.86M | $107.22M | $102.36M | $108.09M | $118.43M | $123.39M | $122.15M | $171.64M |
Avg Forecast | $148.92M | $155.17M | $152.48M | $160.26M | $131.15M | $136.17M | $133.94M | $140.66M | $115.20M | $117.95M | $116.42M | $119.42M | $102.10M | $103.61M | $107.07M | $110.35M | $95.50M | $95.27M |
High Forecast | $148.92M | $155.17M | $152.48M | $160.26M | $131.15M | $136.71M | $133.94M | $140.66M | $117.66M | $117.96M | $116.42M | $119.42M | $102.10M | $103.61M | $107.07M | $110.35M | $95.50M | $95.27M |
Low Forecast | $148.92M | $155.17M | $152.48M | $160.26M | $131.15M | $135.56M | $133.94M | $140.66M | $113.97M | $117.94M | $116.42M | $119.42M | $102.10M | $103.61M | $107.07M | $110.35M | $95.50M | $95.27M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.95% | 0.94% | 0.90% | 1.00% | 1.04% | 1.11% | 1.12% | 1.28% | 1.80% |
Warby Parker EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 |
EPS | - | - | - | - | - | - | - | - | - | $-0.15 | $-0.14 | $-0.09 | $-0.18 | $-0.21 | $-0.28 | $-0.30 | $-0.41 | $-1.45 |
Avg Forecast | $0.06 | $0.09 | $0.08 | $0.10 | $0.02 | $0.05 | $0.05 | $0.07 | $0.01 | $0.01 | $0.02 | $0.04 | $-0.00 | $0.03 | $-0.02 | - | $-0.09 | $-0.52 |
High Forecast | $0.06 | $0.09 | $0.08 | $0.10 | $0.02 | $0.07 | $0.05 | $0.07 | $0.01 | $0.01 | $0.02 | $0.04 | $-0.00 | $0.03 | $-0.02 | - | $-0.09 | $-0.52 |
Low Forecast | $0.06 | $0.09 | $0.08 | $0.10 | $0.02 | $0.03 | $0.05 | $0.07 | $0.01 | $0.01 | $0.02 | $0.04 | $-0.00 | $0.03 | $-0.02 | - | $-0.09 | $-0.52 |
Surprise % | - | - | - | - | - | - | - | - | - | -19.26% | -6.08% | -2.07% | 252.10% | -7.90% | 13.27% | -68.98% | 4.55% | 2.77% |
Warby Parker Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COO | Cooper Companies | $104.86 | $298.00 | 184.19% | Buy |
ANGO | AngioDynamics | $6.74 | $15.00 | 122.55% | Buy |
TFX | Teleflex | $207.33 | $304.82 | 47.02% | Buy |
HAE | Haemonetics | $73.53 | $104.33 | 41.89% | Buy |
KRMD | KORU Medical Systems | $2.68 | $3.75 | 39.93% | Buy |
BDX | Becton, Dickinson and Company | $234.33 | $283.27 | 20.89% | Buy |
WST | West Pharmaceutical Services | $314.77 | $345.33 | 9.71% | Buy |
NVST | Envista | $21.28 | $23.13 | 8.69% | Hold |
ALC | Alcon | $92.17 | $93.89 | 1.87% | Buy |
BLFS | BioLife Solutions | $25.56 | $26.00 | 1.72% | Buy |
MMSI | Merit Medical Systems | $99.08 | $100.78 | 1.72% | Buy |
ICUI | ICU Medical | $172.00 | $172.00 | - | Buy |
WRBY | Warby Parker | $17.57 | $17.00 | -3.24% | Buy |
HOLX | Hologic | $83.72 | $80.43 | -3.93% | Buy |
RMD | ResMed | $243.61 | $219.13 | -10.05% | Hold |
LMAT | LeMaitre Vascular | $96.35 | $85.25 | -11.52% | Buy |
ATR | AptarGroup | $168.26 | $138.00 | -17.98% | Buy |
WRBY Forecast FAQ
Is Warby Parker a good buy?
Yes, according to 12 Wall Street analysts, Warby Parker (WRBY) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 58.33% of WRBY's total ratings.
What is WRBY's price target?
Warby Parker (WRBY) average price target is $17 with a range of $11 to $20, implying a -3.24% from its last price of $17.57. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Warby Parker stock go up soon?
According to Wall Street analysts' prediction for WRBY stock, the company can go down by -3.24% (from the last price of $17.57 to the average price target of $17), up by 13.83% based on the highest stock price target, and down by -37.39% based on the lowest stock price target.
Can Warby Parker stock reach $30?
WRBY's average twelve months analyst stock price target of $17 does not support the claim that Warby Parker can reach $30 in the near future.
What is Warby Parker's current price target trend?
2 Wall Street analysts forecast a $16.5 price target for Warby Parker (WRBY) this month, down -6.09% from its last price of $17.57. Compared to the last 3 and 12 months, the average price target increased by 0.57% and decreased by -2.68%, respectively.
What are Warby Parker's analysts' financial forecasts?
Warby Parker's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $756.71M (high $757.47M, low $755.87M), average EBITDA is $-70.786M (high $-70.707M, low $-70.856M), average net income is $23.51M (high $26.05M, low $20.97M), average SG&A $541.92M (high $542.46M, low $541.31M), and average EPS is $0.196 (high $0.217, low $0.175). WRBY's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $861.31M (high $861.31M, low $861.31M), average EBITDA is $-80.57M (high $-80.57M, low $-80.57M), average net income is $40.6M (high $40.6M, low $40.6M), average SG&A $616.82M (high $616.82M, low $616.82M), and average EPS is $0.338 (high $0.338, low $0.338).
Did the WRBY's actual financial results beat the analysts' financial forecasts?
Based on Warby Parker's last annual report (Dec 2022), the company's revenue was $598.11M, beating the average analysts forecast of $590.83M by 1.23%. Apple's EBITDA was $-79.339M, beating the average prediction of $-55.269M by 43.55%. The company's net income was $-110M, missing the average estimation of $1.09M by -10194.20%. Apple's SG&A was $452.26M, beating the average forecast of $423.12M by 6.89%. Lastly, the company's EPS was $-0.96, missing the average prediction of $0.00911 by -10641.34%. In terms of the last quarterly report (Sep 2023), Warby Parker's revenue was $169.85M, beating the average analysts' forecast of $164.7M by 3.13%. The company's EBITDA was $-19.767M, beating the average prediction of $-15.407M by 28.30%. Warby Parker's net income was $-17.413M, missing the average estimation of $935.23K by -1961.89%. The company's SG&A was $112.5M, missing the average forecast of $117.95M by -4.62%. Lastly, the company's EPS was $-0.15, missing the average prediction of $0.00779 by -2026.04%